Latest filing published 21 May 2026 for Envista Holdings Corp. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Kieran Gallahue is a declared insider at 4 companies (board member); the most frequent names are Edwards Lifesciences Corp, Envista Holdings Corp and Arena Pharmaceuticals Inc. In total, 17 filings cover trades dated from 7 May 2021 to 19 May 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 21 May 2026, the filings show a share grant in Envista Holdings Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations